{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:39:09Z","timestamp":1777959549066,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Qiagen"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.ijid.2020.03.010","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T08:29:53Z","timestamp":1584520193000},"page":"S72-S77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S","title":["Cost-effectiveness of IGRA\/QFT-Plus for TB screening of migrants in Oman"],"prefix":"10.1016","volume":"92","author":[{"given":"Seif","family":"Al Abri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Kowada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"Yaqoubi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sulien","family":"Al Khalili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nduku","family":"Ndunda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eskild","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2020.03.010_bib0005","doi-asserted-by":"crossref","first-page":"d4281","DOI":"10.1136\/bmj.d4281","article-title":"Tuberculosis in the UK\u2014time to regain control","volume":"343","author":"Abubakar","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2020.03.010_bib0010","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/S0140-6736(16)31008-X","article-title":"Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519\u2008955 migrants screened before entry to England, Wales, and Northern Ireland","volume":"388","author":"Aldridge","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2020.03.010_bib0015","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-2600(17)30060-7","article-title":"Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study","volume":"5","author":"Andrews","year":"2017","journal-title":"Lancet Respir Med"},{"issue":"3","key":"10.1016\/j.ijid.2020.03.010_bib0020","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00655-2019","article-title":"The global prevalence of latent tuberculosis: a systematic review and meta-analysis","volume":"54","author":"Cohen","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2020.03.010_bib0025","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1023\/B:QURE.0000021320.89524.64","article-title":"Feasibility and reliability of health-related quality of life measurements among tuberculosis patients","volume":"13","author":"Dion","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ijid.2020.03.010_bib0030","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00591-2018","article-title":"Screening for tuberculosis in migrants and visitors from high incidence settings: present and future perspectives","author":"Dobler","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2020.03.010_bib0035","series-title":"Cost-effectiveness in health and medicine","author":"Gold","year":"1996"},{"key":"10.1016\/j.ijid.2020.03.010_bib0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/resp.13272","article-title":"Update on tuberculosis biomarkers: from correlates of risk, to correlates of active disease and of cure from disease","volume":"23","author":"Goletti","year":"2018","journal-title":"Respirology"},{"key":"10.1016\/j.ijid.2020.03.010_bib0045","article-title":"The effectiveness and cost-effectiveness of screening for latent tuberculosis among migrants in the EU\/EEA: a systematic review","volume":"23","author":"Greenaway","year":"2018","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijid.2020.03.010_bib0050","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-7525-7-14","article-title":"Measuring health-related quality of life in tuberculosis: a systematic review","volume":"7","author":"Guo","year":"2009","journal-title":"Health Qual Life Outcomes"},{"issue":"December","key":"10.1016\/j.ijid.2020.03.010_bib0055","article-title":"Quantitative interferon gamma release assay and tuberculin skin test results to predict incident tuberculosis: a prospective cohort study","author":"Gupta","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.ijid.2020.03.010_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002152","article-title":"The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling","volume":"13","author":"Houben","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijid.2020.03.010_bib0065","first-page":"555","article-title":"Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial","volume":"60","author":"International Union Against Tuberculosis","year":"1982","journal-title":"Bull World Health Organ"},{"issue":"May (3)","key":"10.1016\/j.ijid.2020.03.010_bib0070","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.tube.2012.02.001","article-title":"Characteristics of non-clustered tuberculosis in a low burden country","volume":"92","author":"Kamper-J\u00f8rgensen","year":"2012","journal-title":"Tuberculosis (Edinb)"},{"issue":"March","key":"10.1016\/j.ijid.2020.03.010_bib0075","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1471-2334-12-60","article-title":"Migrant tuberculosis: the extent of transmission in a low burden country","volume":"12","author":"Kamper-J\u00f8rgensen","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2020.03.010_bib0080","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tmaid.2016.05.010","article-title":"Cost effectiveness of interferon-gamma release assay for tuberculosis screening using three months of rifapentine and isoniazid among long-term expatriates from low to high incidence countries","volume":"14","author":"Kowada","year":"2016","journal-title":"Travel Med Infect Dis"},{"key":"10.1016\/j.ijid.2020.03.010_bib0085","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1136\/thoraxjnl-2013-203254","article-title":"Migration and tuberculosis in the UK: targeting screening for latent infection to those at greatest risk of disease","volume":"68","author":"Kruijshaar","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.ijid.2020.03.010_bib0090","doi-asserted-by":"crossref","first-page":"840","DOI":"10.5588\/ijtld.17.0036","article-title":"Tuberculosis and latent tuberculous infection screening of migrants in Europe: comparative analysis of policies, surveillance systems and results","volume":"21","author":"Kunst","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2020.03.010_bib0095","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1128\/JCM.39.3.855-861.2001","article-title":"Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas","volume":"39","author":"Lillebaek","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2020.03.010_bib0100","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1183\/09031936.00214014","article-title":"Towards tuberculosis elimination: an action framework for low-incidence countries","volume":"45","author":"L\u00f6nnroth","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2020.03.010_bib0105","doi-asserted-by":"crossref","first-page":"624","DOI":"10.5588\/ijtld.16.0845","article-title":"Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points","volume":"21","author":"L\u00f6nnroth","year":"2017","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijid.2020.03.010_bib0110","series-title":"Review of available evidence on the use of bedaquiline for the treatment of multidrug-resistant tuberculosis: data analysis report for the World Health Organization","author":"Mbuagbaw","year":"2017"},{"key":"10.1016\/j.ijid.2020.03.010_bib0115","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12879-017-2245-8","article-title":"Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine","volume":"17","author":"McClintock","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijid.2020.03.010_bib0120","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1714283","article-title":"Four months of rifampin or nine months of isoniazid for latent tuberculosis in adults","volume":"379","author":"Menzies","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2020.03.010_bib0125","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00391-2019","article-title":"Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe","volume":"53","author":"Migliori","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2020.03.010_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064898","article-title":"Tuberculosis recurrence after completion treatment in a European city: reinfection or relapse?","volume":"8","author":"Millet","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2020.03.010_bib0135","series-title":"Cost-effectiveness analysis in health: a practical approach","author":"Muennig","year":"2008"},{"key":"10.1016\/j.ijid.2020.03.010_bib0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2020.03.010_bib0145","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1473-3099(11)70069-X","article-title":"Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis","volume":"11","author":"Pareek","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2020.03.010_bib0150","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S1473-3099(19)30283-X","article-title":"Latent tuberculosis infection: diagnostic tests and when to treat. Lancet Infect Dis. 2019;19:231\u201333 and authors reply","volume":"19","author":"Petersen","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2020.03.010_bib0155","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(19)30024-8","article-title":"Building a tuberculosis-free world: the Lancet Commission on tuberculosis","volume":"393","author":"Reid","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ijid.2020.03.010_bib0160","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02077-2018","article-title":"Guidance for programmatic management of latent tuberculosis infection in the European Union\/European Economic Area","volume":"53","author":"Rosales-Klintz","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijid.2020.03.010_bib0165","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/978-94-007-7606-7_3","article-title":"Markov Model theory","volume":"797","author":"Sarich","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ijid.2020.03.010_bib0170","doi-asserted-by":"crossref","first-page":"439","DOI":"10.15585\/mmwr.mm6819a3","article-title":"Tuberculosis screening, testing, and treatment of U.S. health care personnel: recommendations from the National Tuberculosis Controllers Association and CDC, 2019","volume":"68","author":"Sosa","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2020.03.010_bib0175","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jinf.2019.08.018","article-title":"QuantiFERON TB Gold Plus for the diagnosis of tuberculosis: a systematic review and meta-analysis","volume":"79","author":"Sotgiu","year":"2019","journal-title":"J Infect"},{"key":"10.1016\/j.ijid.2020.03.010_bib0180","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2020.03.010_bib0185","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1378\/chest.115.5.1248","article-title":"The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis: derivation of a pulmonary tuberculosis prediction model","volume":"115","author":"Tattevin","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2020.03.010_bib0190","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023412","article-title":"Immigrant screening for latent tuberculosis infection: numbers needed to test and treat, a Norwegian population-based cohort study","volume":"9","author":"Winje","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijid.2020.03.010_bib0195","series-title":"Global action framework for TB research. Geneva","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.ijid.2020.03.010_bib0200","series-title":"Public\u2013private mix for TB prevention and care: a roadmap. Geneva","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.ijid.2020.03.010_bib0205","series-title":"WHO Global Tuberculosis Report","year":"2019"},{"key":"10.1016\/j.ijid.2020.03.010_bib0210","article-title":"Screening migrants from tuberculosis high endemic countries for latent TB in a low endemic setting","author":"Yaquobi","year":"2020","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.ijid.2020.03.010_bib0215","doi-asserted-by":"crossref","first-page":"965","DOI":"10.5588\/ijtld.16.0935","article-title":"Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection","volume":"21","author":"Zenner","year":"2017","journal-title":"Int J Tuberc Lung Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220301296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971220301296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:48:47Z","timestamp":1761119327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971220301296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":43,"alternative-id":["S1201971220301296"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2020.03.010","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness of IGRA\/QFT-Plus for TB screening of migrants in Oman","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2020.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}